Literature DB >> 3291373

Nitrofurantoin--current concepts.

B A Cunha1.   

Abstract

Bacterial drug resistance has become a major concern for urologists in the treatment of urinary tract infection (UTI). One drug which has managed to avoid such resistance problems in its thirty years of use is nitrofurantoin. Nitrofurantoin is effective therapeutically for the treatment of acute lower tract infections, chronic UTI, and for the suppression of catheter-associated bacteria. On a prophylactic basis it is used to sterilize urine before TURP and to prevent chronic reinfection. Its unique mechanism of action, site specificity, achievement of high urinary levels and low serum concentrations, and its effectiveness against both gram-negative and gram-positive bacteria provide many advantages in UTI therapy that many of the newer agents do not. Adverse drug reactions, especially pulmonary toxicity, are extremely rare, and nitrofurantoin maintains an excellent safety profile.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291373     DOI: 10.1016/0090-4295(88)90460-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections.

Authors:  Burke A Cunha; Paul E Schoch; Jean R Hage
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

Authors:  B A Cunha; C B Cunha; B Lam; J Giuga; J Chin; V F Zafonte; S Gerson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-02       Impact factor: 3.267

3.  Sister chromatid exchanges in peripheral lymphocytes of urinary tract infection treated with nitrofurantoin.

Authors:  S Sardaş; A Metin; S Gök; A E Karakaya; N Aykol
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

4.  [Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis].

Authors:  M Ludwig; U Hoyme; W Weidner
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

Review 5.  Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Authors:  Bradley J Gardiner; Andrew J Stewardson; Iain J Abbott; Anton Y Peleg
Journal:  Aust Prescr       Date:  2019-02-01

6.  Prostatic inflammation induces urinary frequency in adult mice.

Authors:  Sanghee Lee; Guang Yang; Wade Bushman
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom.

Authors:  Yu Wan; Ewurabena Mills; Rhoda C Y Leung; Ana Vieira; Xiangyun Zhi; Nicholas J Croucher; Neil Woodford; Elita Jauneikaite; Matthew J Ellington; Shiranee Sriskandan
Journal:  Microb Genom       Date:  2021-12

8.  Association of Adverse Events With Antibiotic Treatment for Urinary Tract Infection.

Authors:  Anne M Butler; Michael J Durkin; Matthew R Keller; Yinjiao Ma; William G Powderly; Margaret A Olsen
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.